Mohamed Nasr

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Nlrp Inflammasome

Top Venues

Pathogens (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Jiantao Zhang, Kellie Hom, Chenyu Zhang, Mohamed Nasr, Volodymyr Gerzanich, Yan-Jin Zhang, Qiyi Tang, Fengtian Xue, J Marc Simard, Richard Y Zhao
SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects. Pathogens (Basel, Switzerland) 13 (1) (2024)
Jiantao Zhang, Kellie Hom, Chenyu Zhang, Mohamed Nasr, Volodymyr Gerzanich, Yan-Jin Zhang, Qiyi Tang, Fengtian Xue, J Marc Simard, Richard Y Zhao
SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects. Pathogens (Basel, Switzerland) 13 (1) (2024)
Jiantao Zhang, Kellie Hom, Chenyu Zhang, Mohamed Nasr, Volodymyr Gerzanich, Yan-Jin Zhang, Qiyi Tang, Fengtian Xue, J Marc Simard, Richard Y Zhao
SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects. Pathogens (Basel, Switzerland) 13 (1) (2024)
Jiantao Zhang, Kellie Hom, Chenyu Zhang, Mohamed Nasr, Volodymyr Gerzanich, Yan-Jin Zhang, Qiyi Tang, Fengtian Xue, J Marc Simard, Richard Y Zhao
SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects. Pathogens (Basel, Switzerland) 13 (1) (2024)
Jiantao Zhang, Qi Li, Shigehiro A Kawashima, Mohamed Nasr, Fengtian Xue, Richard Y Zhao
Improving Drug Sensitivity of HIV-1 Protease Inhibitors by Restriction of Cellular Efflux System in a Fission Yeast Model. Pathogens (Basel, Switzerland) 11 (7) (2022)